IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice

被引:231
作者
Biedermann, T
Zimmermann, S
Himmelrich, H
Gumy, A
Egeter, A
Sakrauski, AK
Seegmüller, I
Voigt, H
Launois, P
Levine, AD
Wagner, H
Heeg, K
Louis, JA [1 ]
Röcken, M
机构
[1] Univ Lausanne, Inst Biochem, WHO Immunol Res & Training Ctr, Lausanne, Switzerland
[2] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany
[3] Tech Univ Munich, Dept Microbiol, D-8000 Munich, Germany
[4] Univ Marburg, Dept Microbiol, Marburg, Germany
[5] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
关键词
D O I
10.1038/ni725
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunity to infection with intracellular pathogens is regulated by interleukin 12 (IL-12), which mediates protective T helper type I (T(H)1) responses, or IL-4, which induces T(H)2 cells and susceptibility. Paradoxically, we show here that when present during the initial activation of dendritic cells (DCs) by infectious agents, IL-4 instructed DCs to produce IL-12 and promote T(H)1 development. This T(H)1 response established resistance to Leishmania major in susceptible BALB/c mice. When present later, during the period of T cell priming, IL-4 induced T(H)2 differentiation and progressive leishmaniasis in resistant mice. Because immune responses developed via the consecutive activation of DCs and then T cells, the contrasting effects of IL-4 on DC development and T cell differentiation led to immune responses that had opposing functional phenotypes.
引用
收藏
页码:1054 / 1060
页数:7
相关论文
共 56 条
[11]  
Egeter O, 2000, CANCER RES, V60, P1515
[12]   Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice [J].
Erb, KJ ;
Ruger, B ;
vonBrevern, M ;
Ryffel, B ;
Schimpl, A ;
Rivett, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (02) :329-339
[13]   USE OF THE CTL44 CELL-LINE, A DERIVATIVE OF CTL/L CELLS, TO IDENTIFY AND QUANTIFY MOUSE INTERLEUKIN-4 BY BIOASSAY [J].
FAVRE, N ;
ERB, P .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 164 (02) :213-220
[14]   Elements of immunity - The instructive role of innate immunity in the acquired immune response [J].
Fearon, DT ;
Locksley, RM .
SCIENCE, 1996, 272 (5258) :50-54
[15]   IL-4 exacerbates disease in a Th1 cell transfer model of colitis [J].
Fort, MM ;
Lesley, R ;
Davidson, NJ ;
Menon, S ;
Brombacher, F ;
Leach, MW ;
Rennick, DM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2793-2800
[16]   TREATMENT OF ESTABLISHED RENAL-CANCER BY TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-4 [J].
GOLUMBEK, PT ;
LAZENBY, AJ ;
LEVITSKY, HI ;
JAFFEE, LM ;
KARASUYAMA, H ;
BAKER, M ;
PARDOLL, DM .
SCIENCE, 1991, 254 (5032) :713-716
[17]   RECOMBINANT INTERLEUKIN-12 CURES MICE INFECTED WITH LEISHMANIA-MAJOR [J].
HEINZEL, FP ;
SCHOENHAUT, DS ;
RERKO, RM ;
ROSSER, LE ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) :1505-1509
[18]   InBALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease [J].
Himmelrich, H ;
Launois, P ;
Maillard, I ;
Biedermann, T ;
Tacchini-Cottier, F ;
Locksley, RM ;
Röcken, M ;
Louis, JA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4819-4825
[19]   Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells [J].
Hochrein, H ;
O'Keeffe, M ;
Luft, T ;
Vandenabeele, S ;
Grumont, RJ ;
Maraskovsky, E ;
Shortman, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (06) :823-833
[20]   Resistance to Leishmania major induced by tolerance to a single antigen [J].
Julia, V ;
Rassoulzadegan, M ;
Glaichenhaus, N .
SCIENCE, 1996, 274 (5286) :421-423